BAIAP3

Across TCGA pan-cancer cohorts, BAIAP3 RNA differs between tumor and matched normal tissue in 8 of 18 cancer types tested, making tumor–normal expression one of BAIAP3’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where BAIAP3 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types BAIAP3 is over-expressed in tumor, although a few such as KIRC and LUSC show the opposite, repressed pattern.

THCA, KIRC, and LUSC are the cancer types where BAIAP3 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in BAIAP3 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	Male	III,IV	+3.300	<.001	11	view →
KIRC	Male	II,III,IV	−1.320	<.001	11	view →
LUSC	Female	All	−1.404	<.001	6	view →
PAAD	All	All	+1.727	<.001	4	view →
ESCA	All	All	−1.001	<.001	2	view →
KIRP	Male	All	−0.942	.001	2	view →
LIHC	Female	III,IV	+0.872	.013	2	view →
PRAD	All	All	+0.851	<.001	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 8 strongest of 8 lineages.

BAIAP3–THCA

Open the THCA breakdown →